Randomized controlled trial of piperacillin-tazobactam, cefepime and ertapenem for the treatment of urinary tract infection caused by extended-spectrum beta-lactamase-producing Escherichia coli

被引:0
|
作者
Yu Bin Seo
Jacob Lee
Young Keun Kim
Seung Soon Lee
Jeong-a Lee
Hyo Youl Kim
Young Uh
Han-Sung Kim
Wonkeun Song
机构
[1] Kangnam Sacred Heart Hospital,Division of Infectious Diseases, Department of Internal Medicine
[2] Hallym University College of Medicine,Department of Internal Medicine
[3] Yonsei University Wonju College of Medicine,Division of Infectious Diseases, Department of Internal Medicine
[4] Hallym University Sacred Heart Hospital,Department of Laboratory Medicine
[5] Hallym University College of Medicine,Department of Laboratory Medicine
[6] Yonsei University Wonju College of Medicine,Department of Laboratory Medicine
[7] Hallym University Sacred Heart Hospital,undefined
[8] Hallym University College of Medicine,undefined
[9] Kangnam Sacred Heart Hospital,undefined
[10] Hallym University College of Medicine,undefined
来源
关键词
Extended spectrum; Beta-lactamase; Piperacillin-tazobactam; Cefepime; Ertapenem;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Randomized controlled trial of piperacillintazobactam, cefepime and ertapenem for the treatment of urinary tract infection caused by extended-spectrum betalactamase-producing Escherichia coli
    Seo, Yu Bin
    Lee, Jacob
    Kim, Young Keun
    Lee, Seung Soon
    Lee, Jeong-a
    Kim, Hyo Youl
    Uh, Young
    Kim, Han-Sung
    Song, Wonkeun
    [J]. BMC INFECTIOUS DISEASES, 2017, 17
  • [2] Piperacillin-Tazobactam Versus Carbapenems for the Treatment of Nonbacteremic Urinary Tract Infections due to Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae
    Tullos, Jordan Brooke
    Stoudenmire, Laura Leigh
    Pouliot, Jonathon David
    [J]. HOSPITAL PHARMACY, 2020, 55 (01) : 44 - 49
  • [3] Epidemiology of urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli
    Ena, Javier
    Arjona, Francisco
    Martinez-Peinado, Carmen
    Lopez-Perezagua, Maria Del Mar
    Amador, Concepcion
    [J]. UROLOGY, 2006, 68 (06) : 1169 - 1174
  • [4] Complicated urinary tract infection caused by extended spectrum beta-lactamase-producing Escherichia coli
    Ranjan, K. P.
    Ranjan, Neelima
    [J]. UROLOGY ANNALS, 2014, 6 (02) : 112 - 113
  • [5] Comparison of the Effectiveness of Piperacillin-Tazobactam and Carbapenems in Nosocomial Infections with Extended-Spectrum Beta-lactamase-Producing Escherichia coli and Klebsiella pneumoniae
    Ayhan, Muge
    Kayaaslan, Bircan
    Hasanoglu, Imran
    Kaya Kalem, Ayse
    Asilturk, Dilek
    Tasyaran, Mehmet Akin
    Guner, Hatice Rahmet
    [J]. MEDITERRANEAN JOURNAL OF INFECTION MICROBES AND ANTIMICROBIALS, 2020, 9
  • [6] Ertapenem in the treatment of bacteremia caused by extended-spectrum beta-lactamase-producing Escherichia coli: a propensity score analysis
    Wu, Un-In
    Chen, Wan-Chin
    Yang, Ching-Shiang
    Wang, Jiun-Ling
    Hu, Fu-Chang
    Chang, Shan-Chwen
    Chen, Yee-Chun
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2012, 16 (01) : E47 - E52
  • [7] Clinical Features of Febrile Urinary Tract Infection Caused by Extended-spectrum Beta-lactamase-producing Escherichia Coli in Children
    Ohnishi, Takuma
    Mishima, Yoshinori
    Takizawa, Shohei
    Tsutsumi, Kentaro
    Amemiya, Atsuko
    Akiyama, Nao
    Kanna, Yukiko
    Asato, Shinya
    Tomita, Mizue
    Ikemiyagi, Masako
    Shikoro, Nobuaki
    Nakazawa, Maki
    Kurihara, Nobuyoshi
    Kamimaki, Isamu
    [J]. KEIO JOURNAL OF MEDICINE, 2020, 69 (02): : 43 - 47
  • [8] Empiric Piperacillin-Tazobactam versus Carbapenems in the Treatment of Bacteraemia Due to Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae
    Ng, Tat Ming
    Khong, Wendy X.
    Harris, Patrick N. A.
    De, Partha P.
    Chow, Angela
    Tambyah, Paul A.
    Lye, David C.
    [J]. PLOS ONE, 2016, 11 (04):
  • [9] In Vitro Susceptibility of piperacillin/tazobactam Against extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae
    Kim, Eui-Chong
    [J]. INFECTION AND CHEMOTHERAPY, 2008, 40 (01): : 49 - 51
  • [10] Is Piperacillin-Tazobactam Effective for the Treatment of Pyelonephritis Caused by Extended-Spectrum β-Lactamase-Producing Organisms?
    Sharara, Sima L.
    Amoah, Joe
    Pana, Zoi D.
    Simner, Patricia J.
    Cosgrove, Sara E.
    Tamma, Pranita D.
    [J]. CLINICAL INFECTIOUS DISEASES, 2020, 71 (08) : E331 - E337